Values First Advisors, Inc. - FREELINE THERAPEUTICS HLDGS ownership

Back to all holdings Add to watchlist

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Values First Advisors, Inc. ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2022$49,000
-12.5%
56,300
+12.3%
0.04%0.0%
Q1 2022$56,000
+21.7%
50,149
+117.6%
0.04%
+29.6%
Q4 2021$46,000
-35.2%
23,048
+10.1%
0.03%
-41.3%
Q3 2021$71,000–20,927–0.05%–
 Download
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,466,508$3,783,5915.70%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders